Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Saahir Khan"'
Autor:
Philip L. Felgner, Frank Zaldivar, Rafael de Assis, Michael J. Stamos, Ariana Naaseh, Abran Gonzales, Philip S. Barie, Rie Nakajima, Alguimantas Jasinskas, Oscar Hernandez Dominguez, Sebastian D. Schubl, Peter Horvath, Anton M. Palma, Shannon Skochko, Weian Zhao, Adam Kelsey, Justine Chinn, Delia F. Tifrea, Saahir Khan, Areg Grigorian, Aarti Jain, Danielle Brabender, Robert Edwards, Kieu Lai, Alpesh Amin, Ava Runge, Suzanne Adelsohn, Cesar Figueroa
BackgroundProtecting health care workers (HCWs) during the coronavirus disease 2019 (COVID-19) pandemic is essential. Serologic testing can identify HCWs who had minimally symptomatic severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d8e95b521133f6c4eccefe7e5f7206d1
https://doi.org/10.1101/2020.12.17.20248430
https://doi.org/10.1101/2020.12.17.20248430
Autor:
Jiin Felgner, Martin A. Schreiber, Oluwasanmi Adenaiye, Rafael Ramiro de Assis, Johannes Irsch, Donald K. Milton, D. Huw Davies, Algis Jasinskas, Philip Hosimer, Rie Nakajima, Anil Bagri, S.-H. Sheldon Tai, Philip L. Felgner, Philip J. Norris, Aarti Jain, Filbert Hong, Paul B. Contestable, Graham Simmons, Andreas Holbro, Michael P. Busch, Charles Noesen, Laurence Corash, Andreas Buser, Mars Stone, Joshua M. Obiero, Manuel Battegay, Saahir Khan
Publikováno v:
Nature Communications
bioRxiv
article-version (status) pre
article-version (number) 1
Nature Communications, Vol 12, Iss 1, Pp 1-9 (2021)
Nature Communications, vol 12, iss 1
bioRxiv
article-version (status) pre
article-version (number) 1
Nature Communications, Vol 12, Iss 1, Pp 1-9 (2021)
Nature Communications, vol 12, iss 1
The current practice for diagnosis of COVID-19, based on SARS-CoV-2 PCR testing of pharyngeal or respiratory specimens in a symptomatic patient at high epidemiologic risk, likely underestimates the true prevalence of infection. Serologic methods can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddf4d0725e2018b8de832287c31b5e4e
https://doi.org/10.1101/2020.04.15.043364
https://doi.org/10.1101/2020.04.15.043364
Autor:
Alguimantas Jasinskas, Rafael Ramiro de Assis, Aarti Jain, Donald K. Milton, Joshua M. Obiero, Filbert Hong, Huw Davies, Oluwasanmi Adenaiye, Rie Nakajima, S.-H. Sheldon Tai, Saahir Khan, Philip L. Felgner
Publikováno v:
bioRxiv
article-version (status) pre
article-version (number) 1
article-version (status) pre
article-version (number) 1
The current practice for diagnosis of SARS-CoV-2 infection relies on PCR testing of nasopharyngeal or respiratory specimens in a symptomatic patient at high epidemiologic risk. This testing strategy likely underestimates the true prevalence of infect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::979ee8c57b885fefd4f38abe87dcb09e
https://doi.org/10.1101/2020.03.24.006544
https://doi.org/10.1101/2020.03.24.006544
Autor:
Algis Jasinskas, Philip L. Felgner, Enrico Gratton, Melody N Toosky, Per Niklas Hedde, Saahir Khan, Aarti Jain, Timothy J Abram, Rafael Ramiro de Assis, Rie Nakajima, Weian Zhao, Trevor Pearce
Publikováno v:
Lab on a Chip
bioRxiv : the preprint server for biology, vol 1, iss 06-01
bioRxiv
article-version (status) pre
article-version (number) 1
bioRxiv : the preprint server for biology, vol 1, iss 06-01
bioRxiv
article-version (status) pre
article-version (number) 1
To detect the presence of antibodies in blood against SARS-CoV-2 in a highly sensitive and specific manner, here we describe a robust, inexpensive ($200), 3D-printable portable imaging platform (TinyArray imager) that can be deployed immediately in a